Business Wire

SecurityScorecard Unveils Sophisticated Cyber Intelligence Powering New Solutions to Counter Threat Actors

Share

SecurityScorecard, the global leader in cybersecurity ratings, today announced the launch of two cyber threat intelligence solutions to deliver an unrivaled view of organizations’ global cyber risk exposure. These new offerings, Attack Surface Intelligence (ASI) and Cyber Risk Intelligence (CRI), provide security teams with contextual intelligence, summarized views, and enriched remediations that are understandable and actionable from practitioner to the board room.

“Adding sophisticated cyber and attack surface intelligence is a natural progression for our customers’ security programs,” said Simon Hunt, chief product officer of SecurityScorecard. “Our robust contextualized and attribution intelligence, built by expert cyber threat researchers, has powered our security ratings for over a decade and, combined with the services of our intelligence team, enables customers who want to go deeper and have greater visibility to understand the ‘why’ and ‘how’ of even the most complex threats.”

Attack Surface Intelligence (ASI)

SecurityScorecard’s Attack Surface Intelligence empowers users with a search engine built within the SecurityScorecard ratings platform to help them identify, contextualize, and prioritize critical threats across their global attack surface. This allows customers to understand the adversary’s next steps, confidently make informed decisions, and reduce disruption. The solution solves for a number of critical challenges that cybersecurity teams are tackling today, including:

  • Threat Investigations: Consolidate existing intelligence sources to gain the contextual information behind threats, vulnerabilities, leaked credentials, and more through API or in-platform use.
  • Vendor Risk Management: Enhance your view of threats and critical vulnerabilities that impact your supply chain security.
  • M&A Due Diligence: Quickly validate the security posture and risks associated with your merger & acquisition (M&A) targets.
  • Cyber Insurance Policy Holder Reviews: Identify active threats and risks associated with your policy holders.
  • Regulators and government agencies: Monitor active threats at the national and geographic level, protect critical infrastructure, and essential services.

Cyber Risk Intelligence (CRI)

Delivered by the SecurityScorecard Threat Research, Intelligence, Knowledge, and Engagement (STRIKE) team, the Cyber Risk Intelligence service leverages the power of expert-led, human analysis coupled with deep intelligence sources, including ASI, to provide organizations with clarity and tailored advice on mitigation controls. With CRI, organizations can arm their threat intelligence teams with board-ready reports to proactively inform strategic decision-makers and prioritize risk controls.

CRI includes two offerings:

  • CRI Core proactively illuminates an organization’s risk exposure to external cyber threats that aren’t detected by internal security controls, including leaked credentials, imposter domains, hacker chatter, and signs of advanced persistent threats (APT) reconnaissance.
  • CRI’s Custom Investigations enables organizations to partner with SecurityScorecard’s STRIKE Team to meet their threat intelligence needs. Examples of custom investigations include malicious email analysis, leaked data and code discovery, malware analysis, investigation of cyber bullying, hacktivism, botnet tracking, and more.

SecurityScorecard’s STRIKE team is the company’s elite team of cybersecurity experts who have more than 100 years of collective experience in cybersecurity investigations and research. STRIKE Team members have varying backgrounds and experiences working with intelligence services, special operations units, and Fortune 50 cyber threat intelligence teams.

“The combination of CRI and ASI provide a critical advantage for organizations looking to constantly stay one step ahead of threat actors,” said Ryan Sherstobitoff, senior vice president of Threat Research and Intelligence at SecurityScorecard. “By partnering with SecurityScorecard’s STRIKE team, organizations will have an extension of their threat intelligence teams, and significantly reduce their cyber risk while better defending their networks from active and emerging threats.”

ASI gives customers access to SecurityScorecard’s industry-trusted and robust data lakes to investigate threats. CRI layers in unparalleled research and analysis by SecurityScorecard’s STRIKE team to help meet specific needs and inform the business of critical threats that could negatively impact operations and brand reputation.

For more information on ASI and CRI solutions, please visit: https://securityscorecard.com/

About SecurityScorecard

Funded by world-class investors including Evolution Equity Partners, Silver Lake Waterman, Sequoia Capital, GV, Riverwood Capital, and others, SecurityScorecard is the global leader in cybersecurity ratings with more than 12 million companies continuously rated. Founded in 2013 by security and risk experts Dr. Aleksandr Yampolskiy and Sam Kassoumeh, SecurityScorecard's patented rating technology is used by over 30,000 organizations for enterprise risk management, third-party risk management, board reporting, due diligence, cyber insurance underwriting, and regulatory oversight. SecurityScorecard is the first cybersecurity ratings company to offer digital forensics and incident response services, providing a 360-degree approach to security prevention and response for its worldwide customer and partner base. SecurityScorecard continues to make the world a safer place by transforming the way companies understand, improve and communicate cybersecurity risk to their boards, employees and vendors. Every organization has the universal right to their trusted and transparent Instant SecurityScorecard rating. For more information, visit securityscorecard.com or connect with us on LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Derek Delano
SecurityScorecard
ddelano@securityscorecard.io
(646) 457-4513

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release

Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of

Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

Incyte Japan Announces Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press Release

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable

GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press Release

Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus

Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press Release

Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye